Desmarais William 4
4 · TScan Therapeutics, Inc. · Filed Jul 27, 2022
Insider Transaction Report
Form 4
Desmarais William
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-25+30,000→ 30,000 totalExercise: $3.27Exp: 2032-07-24→ Voting Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.